期刊文献+
共找到3篇文章
< 1 >
每页显示 20 50 100
Effect of obstructive sleep apnea on type 2 diabetes mellitus:A comprehensive literature review 被引量:25
1
作者 Srikant Nannapaneni Kannan Ramar Salim Surani 《World Journal of Diabetes》 SCIE CAS 2013年第6期238-244,共7页
Obstructive sleep apnea(OSA)is frequently associated with obesity and metabolic syndrome.Also frequently associated with metabolic syndrome is type 2 diabetes mellitus(T2DM).Therefore,it is common to find OSA and T2DM... Obstructive sleep apnea(OSA)is frequently associated with obesity and metabolic syndrome.Also frequently associated with metabolic syndrome is type 2 diabetes mellitus(T2DM).Therefore,it is common to find OSA and T2DM together in individuals with metabolic syndrome.Additionally,both OSA and T2DM have a common pathophysiological link with development of insulin resistance.Individuals with severe insulin resistance are likely to have inadequate glycemic control.Long standing poorly controlled T2DM is associated with debilitating microvascular complications such as retinopathy,nephropathy,neuropathy and macrovascular complications such as coronary artery and cerebrovascular disease.There is extensively published literature exploring the cause-effect relationship between OSA and T2DM.In this article we provide an in-depth review of the complex pathophysiological mechanisms linking OSA to T2DM.Specifically,this review focusses on the effect of OSA on the microvascular complications of T2DM such as retinopathy,nephropathy and neuropathy.Additionally,we review the current literature on the effect of continuous positive airway pressure use in individuals with T2DM and OSA. 展开更多
关键词 SLEEP APNEA and DIABETES OBSTRUCTIVE SLEEP APNEA and DIABETIC COMPLICATIONS OBSTRUCTIVE SLEEP APNEA DIABETIC COMPLICATIONS SLEEP related breathing disorder DIABETES
下载PDF
Are diabetic patients being screened for sleep related breathing disorder? 被引量:1
2
作者 Salim Surani 《World Journal of Diabetes》 SCIE CAS 2013年第5期162-164,共3页
Prevalence of both diabetes mellitus and obstructive sleep apnea(OSA)is high among general population.Both of these conditions are associated with significant morbidity.OSA affects approximately 25%of men and 9%of wom... Prevalence of both diabetes mellitus and obstructive sleep apnea(OSA)is high among general population.Both of these conditions are associated with significant morbidity.OSA affects approximately 25%of men and 9%of women,and its prevalence is even higher among obese,Hispanics,African American and diabetic patients.Diabetes on the other hand besides having high prevalence in general population has even higher prevalence among ethnic populations as Hispanics and African American.Despite the availability of several simple screening tools for OSA,as Berlin questionnaire,STOP-BANG questionnaire,NAMES Criteria,the utility for screening of OSA among the diabetic population remains marginal.This in turn can lead to significant morbidity and complications related to OSA as well as worsening of diabetes mellitus and increase in diabetic complications due to untreated sleep related breathing disorder.It is therefore imperative for the primary care giver to screen for OSA among the diabetic population as a part of their routine evaluation to prevent worsening of diabetes,and its cardiovascular,renal,ophthalmologic and neurological complications. 展开更多
关键词 OBSTRUCTIVE SLEEP APNEA and diabetes MELLITUS OBSTRUCTIVE SLEEP APNEA screening OBSTRUCTIVE SLEEP APNEA and metabolic syndrome
下载PDF
经鼻持续气道正压通气对糖尿病肾病伴阻塞性睡眠呼吸暂停患者VEGF及ICAM-1的影响 被引量:3
3
作者 邓刚 姚丽君 +1 位作者 王小溶 陈望燕 《中国中西医结合肾病杂志》 2012年第7期605-607,共3页
目的:探讨经鼻持续气道正压通气(nasal continuous positive air pressure,nCPAP)治疗对糖尿病肾病(diabeticnephropathy,DN)伴阻塞性睡眠呼吸暂停综合征(obstructive sleep apnoea syndrome,OSAS)患者VEGF及ICAM-1的影响。方法:选择临... 目的:探讨经鼻持续气道正压通气(nasal continuous positive air pressure,nCPAP)治疗对糖尿病肾病(diabeticnephropathy,DN)伴阻塞性睡眠呼吸暂停综合征(obstructive sleep apnoea syndrome,OSAS)患者VEGF及ICAM-1的影响。方法:选择临床确诊的DN伴中度鼾症患者36例,年龄35岁~62岁。随机分为治疗组及对照组,对照组给予常规治疗血糖、血压以及血脂等药物,治疗组系在对照组基础上,同时给予nCPAP治疗3个月,检测指标:(1)血压、血糖、糖化血红蛋白、肾功能、血脂及24h尿蛋白定量等。(2)采用定量酶联免疫吸附试验(ELISA)检测血清VEGF、ICAM-1水平。(3)常规检测血氧饱和度(SaO2)及呼吸暂停低通气指数(apnea-hypopnea index,AHI)。结果:经过3月的nCPAP治疗,两组治疗后患者血压、血肌酐、空腹血糖、糖化血红蛋白以及血脂水平差异无统计学意义(所有P>0.05),两组患者治疗前血氧饱和度、以及AHI未见明显差异;经nCPAP治疗后治疗组比对照组AHI显著下降(P<0.05),夜间MSaO2以及LSaO2大幅提高(P<0.05),治疗后两组血清VEGF、ICAM-1以及24h尿蛋白均有减少,治疗组与对照组相比差异有统计学意义(P<0.05)。结论:在常规疗法基础上,nCPAP治疗可能通过调节OSAS合并DN患者VEGF以及ICAM-1表达水平,从而达到减少尿蛋白,减轻肾脏损伤的目的。 展开更多
关键词 经鼻持续气道正压通气 阻塞性睡眠呼吸暂停综合征 糖尿病肾病 VEGF ICAM-1
下载PDF
上一页 1 下一页 到第
使用帮助 返回顶部